Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Post by NorthBayStreeton Jul 06, 2020 1:21pm
439 Views
Post# 31229464

Nice Sona Write-Up on BMR!

Nice Sona Write-Up on BMR!Sona Nanotech (SONA, CSE) is destined to become one of the great Canadian success stories emerging out of the global pandemic…last Thursday SONA announced a ground breaking development in lateral flow as it moves much closer to bringing its Rapid Response COVID-19 test to market, with potential orders in the tens of millions…robust testing by MRIGlobalrevealed exceptional specificity and sensitivity rates of 96%, unheard of in lateral flow, with an ability to detect the COVID-19 virus in patients with low viral loads in just 10 to 15 minutes compared with RT-PCR testing which typically takes 24 to 48 hours to detect the virus…SONA’s unique Gold nanorods – they have a patent on this technology – is the key, and these nanorods – as opposed to the commonly used nanospheres – could power the next generation of lateral flow diagnostics…SONA has essentially created a new platform for lateral flow with this disruptive technology…the stock is up another $1.26 at $8.23 as of 7:00 am
<< Previous
Bullboard Posts
Next >>